Tender notice
NHS National Generic Pharmaceuticals Transition 2023_1
Notice details
- Published
- Category
- goods
- Buyer region
- North West
- Source
- View official notice
Public buyer
Public buyer
NHS EnglandTender value£104,188,007
- Planned startAs published in the notice
- Planned endAs published in the notice
Work description
Invitation to offer for NHS National Generics Pharmaceuticals Transition 2023_1
Offer reference number: CM/PHG/22/5666
Period of framework agreement: The total maximum duration of the framework agreement to be no more than 18 months with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 48 months.
CM/PHG/22/5666/00 - Transition Products:
CESW 01/08/2023 - 31/01/2024 (6 months) NWLN 01/08/2023 - 31/01/2025 (18 months) LSNE 01/08/2023 - 31/05/2024 (10 months)
CM/PHG/22/5666/01 - Orals Oral (plus non-parenteral) Products:
All regions: 01/08/2023 to 31/05/2024 (10 months)